KR101051859B1 - 3-페닐 치환된 피리도인돌론, 그의 제조 및 치료적 용도 - Google Patents

3-페닐 치환된 피리도인돌론, 그의 제조 및 치료적 용도 Download PDF

Info

Publication number
KR101051859B1
KR101051859B1 KR20057006949A KR20057006949A KR101051859B1 KR 101051859 B1 KR101051859 B1 KR 101051859B1 KR 20057006949 A KR20057006949 A KR 20057006949A KR 20057006949 A KR20057006949 A KR 20057006949A KR 101051859 B1 KR101051859 B1 KR 101051859B1
Authority
KR
South Korea
Prior art keywords
group
compound
formula
dihydro
pyrido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR20057006949A
Other languages
English (en)
Korean (ko)
Other versions
KR20050086421A (ko
Inventor
베르나르 부리에
삐에르 까셀라
파올라 치아페띠
장-마리 데로끄
사미르 제감
이베뜨 뮈노
꺄미유-조지 베르무트
Original Assignee
사노피-아벤티스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피-아벤티스 filed Critical 사노피-아벤티스
Publication of KR20050086421A publication Critical patent/KR20050086421A/ko
Application granted granted Critical
Publication of KR101051859B1 publication Critical patent/KR101051859B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR20057006949A 2002-10-23 2003-10-21 3-페닐 치환된 피리도인돌론, 그의 제조 및 치료적 용도 Expired - Fee Related KR101051859B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/13264 2002-10-23
FR0213264A FR2846329B1 (fr) 2002-10-23 2002-10-23 Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
PCT/FR2003/003110 WO2004041817A1 (fr) 2002-10-23 2003-10-21 Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
KR20050086421A KR20050086421A (ko) 2005-08-30
KR101051859B1 true KR101051859B1 (ko) 2011-07-25

Family

ID=32088223

Family Applications (1)

Application Number Title Priority Date Filing Date
KR20057006949A Expired - Fee Related KR101051859B1 (ko) 2002-10-23 2003-10-21 3-페닐 치환된 피리도인돌론, 그의 제조 및 치료적 용도

Country Status (32)

Country Link
US (2) US7390818B2 (enExample)
EP (1) EP1556382B1 (enExample)
JP (1) JP4488899B2 (enExample)
KR (1) KR101051859B1 (enExample)
CN (1) CN100345850C (enExample)
AR (1) AR041689A1 (enExample)
AT (1) ATE396994T1 (enExample)
AU (1) AU2003296769B2 (enExample)
BR (1) BR0314883A (enExample)
CA (1) CA2502769C (enExample)
CY (1) CY1109785T1 (enExample)
DE (1) DE60321372D1 (enExample)
DK (1) DK1556382T3 (enExample)
EA (1) EA010833B1 (enExample)
ES (1) ES2304546T3 (enExample)
FR (1) FR2846329B1 (enExample)
HR (1) HRP20050362B1 (enExample)
IL (1) IL168133A (enExample)
IS (1) IS2641B (enExample)
MA (1) MA27455A1 (enExample)
ME (1) ME00102B (enExample)
MX (1) MXPA05004349A (enExample)
NO (1) NO331297B1 (enExample)
NZ (1) NZ539866A (enExample)
PL (1) PL214867B1 (enExample)
PT (1) PT1556382E (enExample)
RS (1) RS51605B (enExample)
SI (1) SI1556382T1 (enExample)
TW (1) TWI325864B (enExample)
UA (1) UA79317C2 (enExample)
WO (1) WO2004041817A1 (enExample)
ZA (1) ZA200503231B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
FR2869316B1 (fr) * 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2876377B1 (fr) * 2004-10-11 2007-03-16 Univ Claude Bernard Lyon Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
FR2945950A1 (fr) 2009-05-27 2010-12-03 Elan Pharma Int Ltd Compositions de nanoparticules anticancereuses et procedes pour les preparer
FR2959133A1 (fr) 2010-04-22 2011-10-28 Sanofi Aventis Formulation pharmaceutique anticancereuse
HUE032426T2 (en) 2009-05-27 2017-09-28 Alkermes Pharma Ireland Ltd Inhibition of flake aggregation in nanoparticulate meloxicam formulations
CN107459481A (zh) * 2017-07-25 2017-12-12 广州大学 一种3‑（4‑甲氧基苯基）‑6‑甲氧基‑4‑氯‑5,7‑二溴喹啉的合成方法
EP3919492A4 (en) * 2019-02-01 2022-11-09 Medshine Discovery Inc. TRICYCLIC COMPOUND CONTAINING PYRIMIDINYL GROUP AS C-MET INHIBITOR
CN113329276B (zh) 2020-02-28 2022-10-28 华为技术有限公司 数据传输方法、装置、网关、芯片及存储介质
CN116171156B (zh) * 2020-07-31 2025-07-04 江苏奥赛康药业有限公司 含嘧啶基团的三并环类化合物的盐型、晶型及其制备方法
US20240132446A1 (en) * 2021-05-26 2024-04-25 Refined Technologies, Inc. Compositions and methods for removal of n-methyl-2-pyrrolidone (nmp) degradation products and other foulants from nmp purification systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009129A2 (en) * 1999-08-03 2001-02-08 Novuspharma S.P.A. 1h-pirido[3, 4-b]indol-1-one derivatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
JPH10501686A (ja) 1994-04-13 1998-02-17 ザ ロックフェラー ユニヴァーシティ 神経系の細胞へのｄｎａのａａｖ仲介送達
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
CA2326319A1 (en) 1998-04-02 1999-10-14 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009129A2 (en) * 1999-08-03 2001-02-08 Novuspharma S.P.A. 1h-pirido[3, 4-b]indol-1-one derivatives

Also Published As

Publication number Publication date
DK1556382T3 (da) 2008-10-06
NZ539866A (en) 2008-01-31
BR0314883A (pt) 2005-08-02
NO20051983L (no) 2005-07-22
EA010833B1 (ru) 2008-12-30
UA79317C2 (en) 2007-06-11
FR2846329B1 (fr) 2004-12-03
CN100345850C (zh) 2007-10-31
IS7815A (is) 2005-04-20
ATE396994T1 (de) 2008-06-15
US20080214538A1 (en) 2008-09-04
DE60321372D1 (de) 2008-07-10
MA27455A1 (fr) 2005-07-01
PL214867B1 (pl) 2013-09-30
ES2304546T3 (es) 2008-10-16
ZA200503231B (en) 2006-06-28
ME00102B (me) 2010-10-10
EP1556382B1 (fr) 2008-05-28
CA2502769C (en) 2011-03-15
EP1556382A1 (fr) 2005-07-27
AR041689A1 (es) 2005-05-26
PL376790A1 (pl) 2006-01-09
MEP22208A (en) 2010-06-10
NO20051983D0 (no) 2005-04-22
NO331297B1 (no) 2011-11-21
EA200500521A1 (ru) 2005-12-29
WO2004041817A1 (fr) 2004-05-21
SI1556382T1 (sl) 2008-10-31
US7390818B2 (en) 2008-06-24
CA2502769A1 (en) 2004-05-21
CN1729190A (zh) 2006-02-01
JP2006511498A (ja) 2006-04-06
FR2846329A1 (fr) 2004-04-30
IS2641B (is) 2010-08-15
US20050288318A1 (en) 2005-12-29
JP4488899B2 (ja) 2010-06-23
HK1074446A1 (zh) 2005-11-11
CY1109785T1 (el) 2014-09-10
KR20050086421A (ko) 2005-08-30
RS20050362A (sr) 2007-11-15
IL168133A (en) 2010-05-31
PT1556382E (pt) 2008-07-09
MXPA05004349A (es) 2005-08-26
TWI325864B (en) 2010-06-11
AU2003296769A1 (en) 2004-06-07
US8012991B2 (en) 2011-09-06
HRP20050362A2 (en) 2005-12-31
HRP20050362B1 (hr) 2014-01-31
TW200413368A (en) 2004-08-01
AU2003296769B2 (en) 2010-02-04
RS51605B (sr) 2011-08-31

Similar Documents

Publication Publication Date Title
US8012991B2 (en) Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
AU2010212560B2 (en) Derivatives of azaindoles as inhibitors of protein kinases Abl and Src
US20030187257A1 (en) Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives
US7816368B2 (en) Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
JP4599164B2 (ja) ３位が複素環式基によって置換されたピリドインドロン誘導体、それらの製造法およびそれらの治療用途
RU2364595C2 (ru) Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии
HK1074446B (en) 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
CZ20022083A3 (cs) Nové indenoindolonové sloučeniny, způsob jejich přípravy a farmaceutické kompozice, jež je obsahují

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20140702

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20150720

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20150720

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000